Wittekindt C - Search Results

1

N,N'-Bisbenzylidenebenzene-1,4-diamines and N,N'-Bisbenzylidenenaphthalene-1,4-diamines as Sirtuin Type 2 (SIRT2) Inhibitors.

Kiviranta PH, Leppänen J, Kyrylenko S, Salo HS, Lahtela-Kakkonen M, Tervo AJ, Wittekindt C, Suuronen T, Kuusisto E, Järvinen T, Salminen A, Poso A, Wallén EA. Kiviranta PH, et al. Among authors: wittekindt c. J Med Chem. 2006 Dec 28;49(26):7907-11. doi: 10.1021/jm060566j. J Med Chem. 2006. PMID: 17181175

2

Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.

Rahnasto M, Raunio H, Poso A, Wittekindt C, Juvonen RO. Rahnasto M, et al. Among authors: wittekindt c. J Med Chem. 2005 Jan 27;48(2):440-9. doi: 10.1021/jm049536b. J Med Chem. 2005. PMID: 15658857

3

Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.

Huhtiniemi T, Suuronen T, Rinne VM, Wittekindt C, Lahtela-Kakkonen M, Jarho E, Wallén EA, Salminen A, Poso A, Leppänen J. Huhtiniemi T, et al. Among authors: wittekindt c. J Med Chem. 2008 Aug 14;51(15):4377-80. doi: 10.1021/jm800639h. Epub 2008 Jul 22. J Med Chem. 2008. PMID: 18642893

4

Identification of novel CYP2A6 inhibitors by virtual screening.

Rahnasto MK, Raunio HA, Wittekindt C, Salminen KA, Leppänen J, Juvonen RO, Poso A, Lahtela-Kakkonen MK. Rahnasto MK, et al. Among authors: wittekindt c. Bioorg Med Chem. 2011 Dec 1;19(23):7186-93. doi: 10.1016/j.bmc.2011.09.054. Epub 2011 Oct 4. Bioorg Med Chem. 2011. PMID: 22019468

5

Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.

Korhonen LE, Rahnasto M, Mähönen NJ, Wittekindt C, Poso A, Juvonen RO, Raunio H. Korhonen LE, et al. Among authors: wittekindt c. J Med Chem. 2005 Jun 2;48(11):3808-15. doi: 10.1021/jm0489713. J Med Chem. 2005. PMID: 15916432

6

Comparative and pharmacophore model for deacetylase SIRT1.

Huhtiniemi T, Wittekindt C, Laitinen T, Leppänen J, Salminen A, Poso A, Lahtela-Kakkonen M. Huhtiniemi T, et al. Among authors: wittekindt c. J Comput Aided Mol Des. 2006 Sep;20(9):589-99. doi: 10.1007/s10822-006-9084-9. Epub 2006 Nov 11. J Comput Aided Mol Des. 2006. PMID: 17103016

7

New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis.

Korhonen LE, Turpeinen M, Rahnasto M, Wittekindt C, Poso A, Pelkonen O, Raunio H, Juvonen RO. Korhonen LE, et al. Among authors: wittekindt c. Br J Pharmacol. 2007 Apr;150(7):932-42. doi: 10.1038/sj.bjp.0707173. Epub 2007 Feb 26. Br J Pharmacol. 2007. PMID: 17325652 Free PMC article.

8

Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme--an in silico approach.

Rahnasto M, Wittekindt C, Juvonen RO, Turpeinen M, Petsalo A, Pelkonen O, Poso A, Stahl G, Höltje HD, Raunio H. Rahnasto M, et al. Among authors: wittekindt c. Pharmacogenomics J. 2008 Oct;8(5):328-38. doi: 10.1038/sj.tpj.6500481. Epub 2007 Oct 9. Pharmacogenomics J. 2008. PMID: 17923852

9

Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans.

Tani N, Rahnasto-Rilla M, Wittekindt C, Salminen KA, Ritvanen A, Ollakka R, Koskiranta J, Raunio H, Juvonen RO. Tani N, et al. Among authors: wittekindt c. Eur J Med Chem. 2012 Jan;47(1):270-7. doi: 10.1016/j.ejmech.2011.10.053. Epub 2011 Nov 6. Eur J Med Chem. 2012. PMID: 22100140

10

Apnoeic oxygenation with high flow nasal oxygen for interventional surgery of the larynx and pharynx.

Langer C, Wittekindt C, Arens C, Käbisch S. Langer C, et al. Among authors: wittekindt c. Eur Arch Otorhinolaryngol. 2024 May 16. doi: 10.1007/s00405-024-08726-6. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 38750174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page